Системное кровообращение при высоком нормальном артериальном давлении (связь величин параметров кровообращения со значениями показателей тревожности и вариабельности сердечного ритма)
Диссертация
Гипертоническая болезнь — это во многом психосоматическое заболевание, возникновение которого по ходу онтогенеза зависит от накопления в организме последствий отрицательного психоэмоционального стресса (Henry J., Crim С., 1990; Beevers G., Lip G.Y.H., O’Brien E., 2001). При этом до сих пор не исследована связь между ростом давления у практически здоровых лиц в высокий нормальный диапазон… Читать ещё >
Список литературы
- Бова А.А., Трисветова Е. Л. Роль вазоактивных эндотелиальных факторов в развитии артериальной гипертензии // Кардиология. 2001. -Т.41.-С. 57−58.
- Бойцов С.А., Карпенко М. А. Нерешенные проблемы артериальной гипертензии // Артер. гипертенз.- 2000.- Т.6, № 1.- С. 16−19.
- Кобалава Ж.Д., Котовская Ю. В. Артериальная гипертония 2000 (ключевые аспекты диагностики, дифференциальной диагностики, профилактики и лечения). М.: 2001. — 208 с.
- Маколкин В.И. Артериальная гипертензия фактор риска сердечно-сосудистых заболеваний // РМЖ. — 2002. — Том. 10, № 19. — С. 1−4.
- Михайлов В.М. Вариабельность ритма сердца. Нейрософт: Иваново, 2000. — 182 с.
- Оганов Р. Г. Масленникова Г. Я. Проблемы профилактики сердечно-сосудистых заболеваний в России // Кардиология. 2003. — Т.1. — С. 1219.
- О ходе реализации концепции развития здравоохранения и медицинской науки, задачах на 2001 2005 г. г. и на период до 2010 г.: Доклад МЗ РФ.-М., 2001.- 100 с.
- П.Райгородский Д. Я. Практическая психодиагностика. Самара: Бахрах-М, 2001. — 666 с.
- Рябыкина Г. В. Анализ вариабельности ритма сердца // Кардиология. 1996. — № 10. — С. 87- 97.
- Фролова Е.В., Плавинский С. Л., Моисеева И. Е., Кузнецова О. Ю., Филатов В. Н. Эффективность немедикаментозной коррекции артериальной гипертензии в общей врачебной практике // Кардиология. 2004. — № 2. -С. 35−39.
- Alderman М.Н. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit // Ann. Intern. Med. 1993. -Vol.119.-P. 329−335.
- Anderson E.A., Sinkey C.A., Lawton WJ. et al. Elevated sympathetic nerve activity in borderline hypertension humans: evidence from direct intraneural recording // Hypertension. 1989.-V. 14. — P. 177−183.
- Angelini. Aspects of hypertension management. Lippincot Williams and Wilkins: Philadelphia Baltimore, 2000. — 960 p.
- Barker D.J.P., Osmond C., Golding J., Kuh D., Wadsworth M.E.J. Growth in utero, blood pressure in childhood and adult life and mortality from cardiovascular disease // BMJ. 1989. — Vol.298. — P.564−567.
- Beevers G., Lip G.Y.H., O’Brien E. The pathophysiology of hypertension // BMJ. 2001. — Vol. 322. — P. 912−916.
- Bennet J.C., Plum F. (editors). Cecil textbook of medicine. Philadelphia. The 20th edition. — Philadelphia: Saunders, 1996. — 1341 p.
- Berlowitz D.R., Ash A.S., Hickey E.C., Friedman R.H., Glickman M., Kader B. et al. Inadequate management of blood pressure in a hypertensive population // N Engl J Med. 1998. — Vol. 339. — P. 1957−1963.
- Biegelsen E.S., Loscalzo J. Endothelial function and atherosclerosis // Coron Artery Dis. 1999. — Vol. 10. — P. 241−256.
- Bohr D.F., Dominiczah A.F., Webb R.C. Pathophysiology of the vasculature in hypertension // Hypertension. 1991.-V. 18. — P. 69- 75.
- Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide // Nature. 1990. — Vol. 347. — P. 768 — 770.
- Brashers V.L., Haak S.W., Richardson S J. Alterations of cardiovascular functions // McCance K.L., Huether S.E. (editors). Pathophysiology. The biologic basis for disease in adults and children. The third edition. St Louis: Mosby, 1998.-P. 1024−1092.
- Broten T.P., Miyashiro S. et al. Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilatation // Amer J Physiol. 1992. -Vol. 262.-H. 1579.-H. 1584.
- Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M. Prevalence of hypertension in the US adult population. Results from the
- Third National Health and Nutrition Examination Survey, 1988−1991 // Hypertension. 1995. — Vol. 25. — P. 305−313.
- Cardillo C., Kilcoyne C.M., Quyyimi A.A. et al. Selective debut in ni-tricoxide synthesis may explain the impaired endothelium dependent vasodilatation in patients with essential hypertension // Circulation. — 1998.-V. 97. — P. 138−144.
- Cardillo C., Kilcoyne C.M., Waclawiw M., Cannon R.O. Ill, Panza J. A. Role of endothelin in the increased vascular tone of patients with essential hypertension // Hypertension. 1999. — Vol. 33. — P. 753−758.
- Cardillo C., Panza J. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension // Vase. Med. 1998.-V. 97. — P. 138−144.
- Escudero E., De Lena S., Graff-Iversen S., Almiron M., Cingolani H.E. Left ventricular diastolic function in young men with high normal blood pressure // Can J Cardiol. 1996. — Vol. 12. — P. 959−964.
- Giles T.D. Examining therapeutic goals: population versus individual-based approaches// Am J Hypertens. 2003. — Nov. 16.- p. 26−30.
- Gomez-Cerezo J., Rios Blanco J. J., Suarez Garcia I., Moreno Anaya P., Garcia Raya P., Vazquez-Munoz E., Barbado Hernandez F. J. Noninvasive Study of Endothelial Function in White Coat Hypertension // Hypertension. -2002. Vol. 40. — P. 304−309.
- Gonsales С., Martin С., Hamel E., Galea E., Gomez В., Lluch S., Estrada C. Endothelial cells inhibit the vascular response to adrenergic nerve stimulation by a receptor-mediated mechanism // Can. J. Physiol. 1990. — Vol. 68.-P. 104- 109.
- Guyton A.C., Hall J.E. Textbook of medical physiology. Philadelphia: WB Saunders, 2000. — 1064 c.
- Fesler P., du Cailar P., Mimran A. Heterogeneity of cardiorenal characteristics in normotensive subjects // Hypertension. 2004. — Vol. 43. — P. 219 223.
- Flanagan D.E., Vaile J.C., Petley G.W., Moore V.M., Godsland I.F., Cockington R.A., Robinson J.S., Phillips D.I. The autonomic control of heart rate and insulin resistance in young adults // J Clin Endocrinol Metab. 1999. -Vol. 84. — P.1263−1267.
- Franklin S.S., Gustin W., Wong N.D., Larson M.G., Weber M.A., Kannel W.B. et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study // Circulation. 1997. — Vol. 96. — P. SOS-SIS.
- Folkow B. Physiological aspects of primary hypertension // Physiol. Rev. 1974. — Vol. 62. — P. 347 — 354
- Furchgott R. F, Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine // Nature. 1980. -Vol. 288. — P.373−376.
- Haffner S.M., Ferrannini E., Hazuda H.P., Stern M.P. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals // Hypertension. 1992. — Vol. 20. — P. 38−45.
- Hajjar I., Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988−2000 // JAMA. 2003. -Vol. 290.-P. 199−206.
- Henry J., Crim C. Psychosocial mechanisms of primary hypertension // J. Hypertension. 1990.-V. 8. — P. 783−789.
- Hopkins P.N., Hunt S.C., Wu L.L., Williams G.H., Williams R.R. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? // Cuit Opin Lipido. 1996. — Vol.7. — P.241−253.
- Houston, Meador, Schipani. Handbook of Antihypertensive Therapy. A Hanley & Belfus Publication. Tenth Edition. Baltimore-Philadelphia: Lip-pincot, Williams & Wilkins, 2000. — 176 p.
- Hughes A.D., Schachter M. Hypertension and blood vessels // Br. Med. Bull. 1994. — Vol. 50. — P. 356−70.
- Izzo, Black et al. Hypertension Primer. The Essentials of High Blood Pressure Basic Science, Population Science, and Clinical Management. Second Edition. Baltimore-Philadelphia: Lippincot, Williams & Wilkins, 1999. — 496 P
- Julius S., Valentini M., Palatini P. Overweight and hypertension: a 2-way street? // Hypertension. 2000. — Vol. 35. — P.807−813.
- Just A., Wittman U., Nafz В., Wagner C.D., Ehmke H., Kirchheim H.R., Pontus P.B. The blood pressure buffering capacity of nitric oxide by comparison to the baroreceptor reflex // Am J Physiol Heart Circ Physiol. 1994. -Vol. 267.-H. 521−527.
- Kannel W.B. Elevated systolic blood pressure as a cardiovascular risk factor // Am J Cardiology. 2000, — Vol. 15. — P.251−255.
- Kaufman, McKee. Essentials of Pathophysiology. Baltimore-Philadelphia: Lippincot, Williams & Wilkins, 1996. — 816 p.
- Kawachi I., Sparrow D., Vokonas P. S., Weiss S.T. Decreased heart rate variability in men with phobic anxiety // Am J Cardiol. 1995. — Vol. 75. -P. 882−885.
- Kazumi Т., Kawaguchi A., Hozumi Т., Nagao M., Iwahashi M., Haya-kawa M. Ishihara K., Yoshino G. Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men // Atherosclerosis. 1999. -Vol.142.-P. 113−119.
- Kazumi Т., Kawaguchi A., Katoh J., Iwahashi M., Yoshino G. Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index // J Hypertens. 1999. — Vol. 17. -P.1451−1455.
- Kimura Y., Tomiyama H., Nishikawa E. et al. Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations // Hypertens Res. 1999. — Vol.22. — P. 291−295.
- Lacolley P.J., Lewis S.J., Brody M.J. Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats // Hypertension. 1991. — Vol. 17. — P. 881 — 887.
- Laragh, Brenner. Hypertension. Pathophysiology, Diagnosis, and Management. Second Edition. Baltimore-Philadelphia: Lippincot, Williams & Wilkins, 1995.-3334 p.
- Leitschuh M., Cupples L.A., Kannel W., Gagnon D. Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study // Hypertension. 1991. — Vol 17. — P. 22−27.
- Lenfant C. High blood pressure: some answers, new questions, continuing challenges // JAMA. 1996.-V. 275. — P. 1604- 616.
- Lilly. Pathophysiology of Heart Disease. A Collaborative Project of Medical Students and Faculty. Second Edition. Baltimore-Philadelphia: Lippincot, Williams & Wilkins, — 1997. — 401 p.
- Lonati L., Cuspidi C., Sampieri L. et al. Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives // Cardiology. 1993. — Vol. 83. — P. 298−303.
- Lowe L.P., Greenland P., Ruth K.J., Dyer A.R., Stamler R., Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men // Arch Intern Med. 1998. — Vol.158. -P. 2007−2014.
- MacMahon S., Peto R., Cutler J. et al. Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias // Lancet. 1990. -Vol. 335. — P.765−774.
- Masuo К., Mikami H., Ogihara Т., Tuck M.L. Do reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients? // J Hyper-tens. 1996. — Vol. 9. — P.566−569.
- Masuo K., Mikami H., Ogihara Т., Tuck M.L. Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system // N Engl J Med. 1996. -Vol. 334.-P. 374−381.
- Miller V.M. Interactions between neural and endothelial mechanisms in control of vascular tone // News in physiological sciences. 1991.- Vol. 6.- P. 113−119.
- Mittleman M.A., Maclure M" Sherwood J.B., Mulry R.P., Tofler G.H., Jacobs S.C., Friedman R., Benson H., Muller J.E. Triggering of acute myocardial infarction onset by episodes of anger // Circulation. 1995. — Vol. 92. — P. 1720−1725.
- Nafz В., Just A., StauB H.M., Wagner C.D., Ehmke H., Kirchheim H.R., Persson P. Blood-pressure variability is buffered by nitric oxide // J Auton NervSyst. 1986.-Vol. 57.-P. 181 — 183.
- National High Blood Pressure Education Program Working Group report on primary prevention of hypertension // Arch. Intern. Med. 1993. -Vol.153.-P.186−208.
- Pang C.C.Y. Autonomic control of the venous system in health and disease. Effects of drugs // Pharmacol Ther. 2001. — Vol. 90. — P. 179−230.
- Palatini P., Casiglia E., Pauletto P., Staessen J., Kaciroti N., Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations // Hypertension. 1997. -Vol.30.-P.1267−1273.
- Palatini P., Julius S. Heart rate and the cardiovascular risk // J Hyper-tens. 1997. — Vol.15. — P.3−17.
- Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endo-thelium-dependent vascular relaxation in patients with essential hypertension // N Engl J Med. 1990. — Vol.323. — P. 22−27.
- Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothe-lium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension // Circulation 1993. Vol.87. -P.1468−1474.
- Panza J.A. Endothelium, nitric oxide, and hypertension // Panza J.A., Cannon R.O. Ill, eds. Endothelium, nitric oxide, and atherosclerosis: from basic mechanisms to clinical implications. Armonk, N.Y.: Futura Publishing, 1999. — P.147−62.
- Panza J. A. High-Normal Blood Pressure — More «High» Than «Normal» // N Engl J Med. — 2001. — Vol. 345. P. 1337−1340.
- Psaty B.M., Smith N.L., Siscovick D.S. et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis // JAMA. 1997. — Vol. 277. — P. 739−745.
- Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients // Circulation. 2001. — Vol.104. -P.191−196.
- Rhoades, Tanner. Medical Physiology. Baltimore-Philadelphia: Lip-pincot, Williams & Wilkins, 1995. — 864 p.
- Ramsay L.E., Williams В., Johnston G.D. et al. British Hypertension Society guidelines for hypertension management 1999: summary//BMJ. 1999. -Vol. 319. — P.630−635.
- Sagie A., Larson M.G., Levy D. The natural history of borderline isolated systolic hypertension//N Engl J Med. 1993. — Vol. 329. — P. 1912−1917.
- Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease//Circulation. 2000. — Vol. 101.-P. 1899−1906.
- Schlaich M. P. et al. Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation // Hypertension. 2004. — Vol. 43. — P. 169−175.
- Schork N.J. Genetics of Complex Disease. Approaches, Problems, and Solutions // Am. J. Respir. Crit. Care Med. 1997. — Volume 156, N 4. — S. 103−109.
- Sleight P., Eckberg D.L. Human Baroreflexes in Health and Disease. -Oxford: Clarendon, 1992. 312 p.
- Staessen J.A., Gasowski J., Wang J.G. et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials // Lancet. 2000. — Vol. 355. — P. 865−872.
- Stamler J., Stamler R., Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data // Arch Intern Med. -1993.-Vol. 153.-P. 598−615.
- Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes D.R. Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction // Circulation. 2000. — Vol.101. — P. 948 954.
- Taddei S., Virdis A., Mattei P., Ghiadoni L., Sudano I., Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients // Circulation. 1996. — Vol.94. -P.1298−1303.
- The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Arch. Intern. Med. 1997. — Vol. 157. — P. 2413−2446.
- Trevathan W.R., Smith E.O., McKenna J.J. (editotrs). Evolutionary Medicine. New York: Oxford University Press, 1999. — 432 p.
- UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 // BMJ. 1998. — Vol. 317. — P.703−713
- Whelton P.K., He J., Appel L.J., Cutler J.A., Havas S., Kotchen T.A. et al. Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program // JAMA. -2002. Vol. 288. — P. l882−1888.
- Vasan R.S., Larson M.G., Leip E.P., Kannel W.B., Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: A cohort study // Lancet. 2001. -Vol. 358. — P.1682−1686.
- Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O’Donnell C.J., Kannel W.B. et al. Impact of high-normal blood pressure on the risk of cardiovascular disease // N. Engl. J Med. 2001. — Vol. 345. — P. 1291−1297.
- World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization // http://www.who.int/whr. -2002.
- Yeragani V.K., Balon R., Pohl R., Ramesh C., Glitz D., Weinberg P., Merlos B. Decreased R-R variance in panic disorder patients // Acta Psy-chiatr Scand. 1990. — Vol. 81. — P. 554−559.